Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
This test measures the activity of factor VIII, a protein that helps your blood clot. The result reflects how well factor VIII in your plasma supports normal clot formation in a laboratory assay. The notation 1:20 refers to a standard dilution used in the method to obtain a reliable and comparable measurement.
Your provider may order this test when evaluating easy bruising, frequent nosebleeds, heavy menstrual bleeding, bleeding after procedures, or an unexplained prolonged clotting screen. It can also be used to monitor treatment that replaces or increases factor VIII.
Factor VIII activity helps your care team determine whether you could have hemophilia A, a carrier state, or an acquired problem that lowers this protein. It is also important when assessing bleeding risk before surgery and when deciding on therapies such as desmopressin or factor concentrates. If you receive treatment, the test helps confirm that your factor level responds as expected.
Results can also rise with inflammation, infection, pregnancy, or estrogen therapy, which can affect clotting risk. Because factor VIII is closely linked with von Willebrand factor and other clotting tests, your clinician will often interpret this result together with an aPTT, von Willebrand studies, and sometimes inhibitor testing.
A lower-than-expected factor VIII activity suggests reduced clotting function. Your clinician may consider inherited hemophilia A, a carrier state, von Willebrand factor issues that secondarily reduce factor VIII, or an acquired inhibitor that interferes with factor activity. Additional tests, such as mixing studies, inhibitor assays, or von Willebrand factor measurements, may be ordered to clarify the cause.
Higher-than-expected activity can occur with stress, inflammation, pregnancy, or estrogen use. On its own it does not diagnose a condition, but it can contribute to your overall clotting risk assessment. Your provider will discuss whether any repeat testing, changes in medications, or specialist referral are appropriate based on your symptoms, history, and other lab results.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Underfilled citrate tubes, prolonged tourniquet time, delayed processing, or improper storage can distort factor results. Ensure the tube is filled to the mark and processed promptly to improve accuracy.
Recent factor concentrates, desmopressin, antifibrinolytics, or anticoagulants can change the measured activity. Tell your care team about blood thinners, replacement therapy, or infusions received in the days before testing.
Factor VIII behaves as an acute phase reactant. Fever, infection, injury, or surgery can raise levels temporarily. Testing when you are well may be recommended for a baseline assessment.
Pregnancy and estrogen-containing therapies often increase factor VIII activity. Your provider may interpret results using clinical context or repeat testing after pregnancy or medication changes.
Von Willebrand disease, liver disease, and autoimmune inhibitors can affect factor VIII activity. Your clinician may order companion tests to pinpoint the cause of low activity.
If you receive desmopressin or factor replacement, timing of the blood draw relative to the dose strongly influences the result. Follow the requested schedule for pre- or post-dose sampling.
References